Anika Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Anika Therapeutics (ANIK) Tops Q1 EPS
May 7, 2020 5:06 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.45, $0.51 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $31.53 million.
Anika delivered solid first quarter results and made significant progress towards advancing our strategic plan, including... More



